Xeris Biopharma Holdings, Inc. (XERS)
6.375
-0.06
(-0.86%)
USD |
NASDAQ |
May 14, 16:00
6.375
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Investing (Quarterly) : -0.325M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zoetis, Inc. | -87.00M |
| Harrow, Inc. | -18.20M |
| Corcept Therapeutics, Inc. | 4.542M |
| Assertio Holdings, Inc. | 15.11M |
| Johnson & Johnson | -1.04B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.87M |
| Cash from Financing (Quarterly) | -8.837M |
| Free Cash Flow | 47.52M |
| Free Cash Flow Per Share (Quarterly) | 0.0537 |
| Free Cash Flow to Equity (Quarterly) | 9.09M |
| Free Cash Flow to Firm (Quarterly) | 16.43M |
| Free Cash Flow Yield | 4.29% |